Immunara Overview
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Immunara General Information
Description
Developer of an artificial intelligence platform designed for precision immunology research and immune-mediated disease analysis. The company's platform leverages biological foundation models and integrates multimodal data sources to map complex immune system interactions, identify novel biomarkers, characterize disease mechanisms, and generate actionable insights across immune-mediated conditions, enabling pharmaceutical and biotechnology researchers to accelerate target discovery, improve therapeutic development pipelines, and advance the understanding of immune-driven pathologies with accuracy and efficiency.
Contact Information
Website
www.immunara.aiCorporate Office
- San Francisco, CA
- United States
Corporate Office
- San Francisco, CA
- United States
Immunara Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 29-Oct-2026 | Completed | Out of Business | |||
| 2. Accelerator/Incubator | 25-Jun-2026 | Completed | Startup | |||
| 1. Seed Round | 16-Mar-2026 | Completed | Startup |
Immunara FAQs
-
Where is Immunara headquartered?
Immunara is headquartered in San Francisco, CA.
-
What industry is Immunara in?
Immunara’s primary industry is Discovery Tools (Healthcare).
-
Is Immunara a private or public company?
Immunara is a Private company.
-
What is Immunara’s current revenue?
The current revenue for Immunara is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process